Pivotal role for aspartate-80 in the regulation of dopamine D2 receptor affinity for drugs and inhibition of adenylyl cyclase
- PMID: 1828858
Pivotal role for aspartate-80 in the regulation of dopamine D2 receptor affinity for drugs and inhibition of adenylyl cyclase
Abstract
An aspartate residue corresponding to aspartate-80 of dopamine D2 receptors is strictly conserved among receptors that couple to guanine nucleotide-binding proteins. Mutation of this residue alters the function of several classes of neurotransmitter receptors. Dopamine D2 receptors couple to the guanine nucleotide-binding protein Gi to inhibit adenylyl cyclase (ATP-pyrophosphate-lyase, cyclizing; EC 4.6.1.1). Like other Gi-coupled receptors, the binding of agonists and some antagonists to D2 receptors is sensitive to pH and sodium. In the present report, we demonstrate that substitution of an alanine or glutamate residue for aspartate-80 severely impairs inhibition of adenylyl cyclase by D2 receptors and also abolishes or decreases the regulation of the affinity of D2 receptors for agonists and substituted benzamide antagonists by sodium and pH. Our data support the hypothesis that the conformation of D2 receptors is maintained by interactions of monovalent cations with aspartate-80. The regulation of D2 receptors by this interaction has important consequences for the affinity of D2 receptors for ligands and for signal transduction by D2 receptors.
Similar articles
-
Regulation of dopamine D2 receptors by sodium and pH.Mol Pharmacol. 1991 Apr;39(4):570-8. Mol Pharmacol. 1991. PMID: 2017157
-
Characterization of a chimeric human dopamine D3/D2 receptor functionally coupled to adenylyl cyclase in Chinese hamster ovary cells.Mol Pharmacol. 1995 Aug;48(2):344-51. Mol Pharmacol. 1995. PMID: 7651368
-
Activation of heterologously expressed D3 dopamine receptors: comparison with D2 dopamine receptors.Mol Pharmacol. 1994 Jan;45(1):51-60. Mol Pharmacol. 1994. PMID: 8302280
-
Natriuretic peptide receptor-C signaling and regulation.Peptides. 2005 Jun;26(6):1044-59. doi: 10.1016/j.peptides.2004.09.023. Epub 2005 Apr 8. Peptides. 2005. PMID: 15911072 Review.
-
Multiple dopamine receptors in brain and the pharmacological action of substituted benzamide drugs.Acta Psychiatr Scand Suppl. 1984;311:109-23. doi: 10.1111/j.1600-0447.1984.tb06863.x. Acta Psychiatr Scand Suppl. 1984. PMID: 6142587 Review.
Cited by
-
Molecular Architecture of G Protein-Coupled Receptors.Drug Dev Res. 1996 Jan 1;37(1):1-38. doi: 10.1002/(SICI)1098-2299(199601)37:1<1::AID-DDR1>3.0.CO;2-S. Drug Dev Res. 1996. PMID: 21921973 Free PMC article.
-
Structure-guided development of heterodimer-selective GPCR ligands.Nat Commun. 2016 Jul 26;7:12298. doi: 10.1038/ncomms12298. Nat Commun. 2016. PMID: 27457610 Free PMC article.
-
Functional domains of the gonadotropin-releasing hormone receptor.Cell Mol Neurobiol. 1995 Feb;15(1):25-42. doi: 10.1007/BF02069557. Cell Mol Neurobiol. 1995. PMID: 7648608 Review.
-
Sodium ions allosterically modulate the M2 muscarinic receptor.Sci Rep. 2020 Jul 7;10(1):11177. doi: 10.1038/s41598-020-68133-9. Sci Rep. 2020. PMID: 32636499 Free PMC article.
-
Mathematical analysis of the sodium sensitivity of the human histamine H3 receptor.In Silico Pharmacol. 2014 Dec;2(1):1. doi: 10.1186/s40203-014-0001-y. Epub 2014 May 24. In Silico Pharmacol. 2014. PMID: 27502620 Free PMC article.